Cost-effectiveness analysis of a complementary health intervention

The case of smoking relapse prevention

Thomas N. Chirikos, Thaddeus A. Herzog, Cathy D. Meade, Monica W Hooper, Thomas H. Brandon

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objectives: We assess the cost-effectiveness of smoking relapse prevention interventions designed to keep quitters from resuming the use of cigarettes. Because relapse prevention is complementary to smoking cessation efforts, the appropriate test of its cost-effectiveness is whether it reduces the incremental cost-effectiveness ratio (ICER) of smoking cessation. The major goal of the study is to carry out such a test. Methods: Data from a randomized trial that ascertained the effectiveness of alternative modes of smoking relapse prevention are combined with ICER estimates of smoking cessation to assess whether relapse prevention is cost-effective. Results: The trial produced convincing evidence that relapse prevention yields statistically significant reductions in the proportion of quitters who are smoking at 24 months postquit. The intervention effects are substantial enough to raise the denominator terms of the smoking cessation ICER and, thereby, offset the amount relapse prevention adds to cost numerator terms. In this sense, smoking relapse prevention tends to pay for itself. Conclusions: Smoking relapse prevention is a highly cost-effective addition to current efforts to curb cigarette consumption. Complementary health interventions of this sort should be assessed by different methods than those commonly found in the cost-effectiveness literature.

Original languageEnglish
Pages (from-to)475-480
Number of pages6
JournalInternational Journal of Technology Assessment in Health Care
Volume20
Issue number4
StatePublished - Sep 1 2004
Externally publishedYes

Fingerprint

Secondary Prevention
Cost-Benefit Analysis
Smoking
Health
Smoking Cessation
Costs and Cost Analysis
Tobacco Products

Keywords

  • Cost-benefit methodology
  • Cost-effectiveness analysis
  • Smoking cessation
  • Smoking economics
  • Smoking prevention and control

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Health Informatics
  • Health Information Management
  • Nursing(all)

Cite this

Cost-effectiveness analysis of a complementary health intervention : The case of smoking relapse prevention. / Chirikos, Thomas N.; Herzog, Thaddeus A.; Meade, Cathy D.; Hooper, Monica W; Brandon, Thomas H.

In: International Journal of Technology Assessment in Health Care, Vol. 20, No. 4, 01.09.2004, p. 475-480.

Research output: Contribution to journalArticle

Chirikos, Thomas N. ; Herzog, Thaddeus A. ; Meade, Cathy D. ; Hooper, Monica W ; Brandon, Thomas H. / Cost-effectiveness analysis of a complementary health intervention : The case of smoking relapse prevention. In: International Journal of Technology Assessment in Health Care. 2004 ; Vol. 20, No. 4. pp. 475-480.
@article{65a81b0b78584f84bf621b6b349afb4c,
title = "Cost-effectiveness analysis of a complementary health intervention: The case of smoking relapse prevention",
abstract = "Objectives: We assess the cost-effectiveness of smoking relapse prevention interventions designed to keep quitters from resuming the use of cigarettes. Because relapse prevention is complementary to smoking cessation efforts, the appropriate test of its cost-effectiveness is whether it reduces the incremental cost-effectiveness ratio (ICER) of smoking cessation. The major goal of the study is to carry out such a test. Methods: Data from a randomized trial that ascertained the effectiveness of alternative modes of smoking relapse prevention are combined with ICER estimates of smoking cessation to assess whether relapse prevention is cost-effective. Results: The trial produced convincing evidence that relapse prevention yields statistically significant reductions in the proportion of quitters who are smoking at 24 months postquit. The intervention effects are substantial enough to raise the denominator terms of the smoking cessation ICER and, thereby, offset the amount relapse prevention adds to cost numerator terms. In this sense, smoking relapse prevention tends to pay for itself. Conclusions: Smoking relapse prevention is a highly cost-effective addition to current efforts to curb cigarette consumption. Complementary health interventions of this sort should be assessed by different methods than those commonly found in the cost-effectiveness literature.",
keywords = "Cost-benefit methodology, Cost-effectiveness analysis, Smoking cessation, Smoking economics, Smoking prevention and control",
author = "Chirikos, {Thomas N.} and Herzog, {Thaddeus A.} and Meade, {Cathy D.} and Hooper, {Monica W} and Brandon, {Thomas H.}",
year = "2004",
month = "9",
day = "1",
language = "English",
volume = "20",
pages = "475--480",
journal = "International Journal of Technology Assessment in Health Care",
issn = "0266-4623",
publisher = "Cambridge University Press",
number = "4",

}

TY - JOUR

T1 - Cost-effectiveness analysis of a complementary health intervention

T2 - The case of smoking relapse prevention

AU - Chirikos, Thomas N.

AU - Herzog, Thaddeus A.

AU - Meade, Cathy D.

AU - Hooper, Monica W

AU - Brandon, Thomas H.

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Objectives: We assess the cost-effectiveness of smoking relapse prevention interventions designed to keep quitters from resuming the use of cigarettes. Because relapse prevention is complementary to smoking cessation efforts, the appropriate test of its cost-effectiveness is whether it reduces the incremental cost-effectiveness ratio (ICER) of smoking cessation. The major goal of the study is to carry out such a test. Methods: Data from a randomized trial that ascertained the effectiveness of alternative modes of smoking relapse prevention are combined with ICER estimates of smoking cessation to assess whether relapse prevention is cost-effective. Results: The trial produced convincing evidence that relapse prevention yields statistically significant reductions in the proportion of quitters who are smoking at 24 months postquit. The intervention effects are substantial enough to raise the denominator terms of the smoking cessation ICER and, thereby, offset the amount relapse prevention adds to cost numerator terms. In this sense, smoking relapse prevention tends to pay for itself. Conclusions: Smoking relapse prevention is a highly cost-effective addition to current efforts to curb cigarette consumption. Complementary health interventions of this sort should be assessed by different methods than those commonly found in the cost-effectiveness literature.

AB - Objectives: We assess the cost-effectiveness of smoking relapse prevention interventions designed to keep quitters from resuming the use of cigarettes. Because relapse prevention is complementary to smoking cessation efforts, the appropriate test of its cost-effectiveness is whether it reduces the incremental cost-effectiveness ratio (ICER) of smoking cessation. The major goal of the study is to carry out such a test. Methods: Data from a randomized trial that ascertained the effectiveness of alternative modes of smoking relapse prevention are combined with ICER estimates of smoking cessation to assess whether relapse prevention is cost-effective. Results: The trial produced convincing evidence that relapse prevention yields statistically significant reductions in the proportion of quitters who are smoking at 24 months postquit. The intervention effects are substantial enough to raise the denominator terms of the smoking cessation ICER and, thereby, offset the amount relapse prevention adds to cost numerator terms. In this sense, smoking relapse prevention tends to pay for itself. Conclusions: Smoking relapse prevention is a highly cost-effective addition to current efforts to curb cigarette consumption. Complementary health interventions of this sort should be assessed by different methods than those commonly found in the cost-effectiveness literature.

KW - Cost-benefit methodology

KW - Cost-effectiveness analysis

KW - Smoking cessation

KW - Smoking economics

KW - Smoking prevention and control

UR - http://www.scopus.com/inward/record.url?scp=8544246485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8544246485&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 475

EP - 480

JO - International Journal of Technology Assessment in Health Care

JF - International Journal of Technology Assessment in Health Care

SN - 0266-4623

IS - 4

ER -